A phase 3 clinical trial finds that stem cells from the umbilical cord may help repair heart damage after a heart attack.
One of the most common causes of death in the world is heart attacks, which may have a lasting effect in terms of damage. Even after emergency treatment, many patients have been left with weak muscles of the heart, which are unable to pump efficiently, exposing them to heart failure in the future. A large clinical trial that was recently completed is a promising development.
Scientists discovered that stem cell therapy can help repair the heart internally, which may change how doctors treat heart attack survivors in the future (1✔ ✔Trusted Source
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)
Go to source
).The Healing Power of Stem Cells
Stem cells are known as the body’s master cells because they can differentiate into a wide range of cells, including muscle, bone, and nerve cells. In this experiment, the authors used mesenchymal stem cells (MSCs) derived from Wharton’s jelly, a gelatinous substance found in the umbilical cord.
These are Wharton-derived MSCs (WJ-MSCs), which have been shown to have potent tissue-repairing and anti-inflammatory properties. Scientists hope to repair damaged heart tissue by using these methods to reduce inflammation, improve blood flow, and promote the growth of new cells, essentially allowing the heart to heal itself.
The PREVENT-TAHA8 Trial: A Landmark Study
The PREVENT-TAHA8 Phase 3 trial included 537 adults who had just experienced an acute heart attack, known as ST-elevation myocardial infarction (STEMI).
Following emergency procedures to open blocked arteries (typically angioplasty and stenting), participants were randomly assigned to receive
- An infusion of WJ-MSCs, or
- A placebo (saline solution)
This was given directly into the coronary artery, which had already caused the heart attack, within days of its occurrence.
Following that, physicians would closely monitor each patient’s heart performance over the course of a few months using high-quality scans and blood tests to assess the quality of the recovery.
Promising Results for Heart Recovery
The outcomes were promising. Patients who received stem cell therapy showed better heart recovery than those who received a placebo. They had:
- Better left ventricular ejection fraction (LVEF) – This is one of the measurements of the efficiency with which the heart expels the blood.
- Reduced scarring and heart tissue damage.
- Reduced inflammation, which is the leading cause of aggravation of heart failure following a heart attack.
Furthermore, the therapy was safe and well-tolerated, with no significant side effects or complications involving the stem cells. This renders it as one of the initial large human experiments that demonstrated the safety and effectiveness of using stem cells in heart repair.
Why This Matters for Future Heart Care
Heart disease typically begins with a heart attack, and patients must take medications and be monitored for the rest of their lives. However, if stem cell therapy is truly capable of restoring heart muscle, it has the potential to transform the treatment of heart attacks.
Rather than simply accepting the damage, doctors could help the heart heal, reducing disability in the long run, reducing hospital readmissions, and improving the quality of life for millions of patients worldwide each year.
Researchers indicate that this study is a novel era of regenerative cardiology. Although further research will be required until it becomes the norm, the future seems bright. Hopefully, in the future, a one-time transplant of stem cells can heal what is lost due to a heart attack.
The Future is Regenerative
The PREVENT-TAHA8 trial is a significant step forward in harnessing the body’s self-healing ability. Scientists are demonstrating that the future of heart disease treatment may include not only stents and surgical procedures, but also cellular repair via stem cells derived from a natural source, the umbilical cord.
With the advancement of science, the dream of the heart healing itself after a heart attack is no longer a figment of imagination but a medical reality.
Reference:
- Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) – (https://www.bmj.com/content/391/bmj-2024-083382)
Source-BMJ